XRCC2 and breast cancer: In addition, previous studies support our findings, reports suggest that overexpression of XRCC2 in rectal cancer predicts higher malignancy and more lymphatic metastasis and that abnormal overexpression of XRCC2 predicts poor prognosis in breast cancer patients (Lin 2011; Qin 2015).